Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Mechanisms of Anti-VEGF Induced Hypertension
This is a completed clinical trial update examining the mechanisms of hypertension induced by anti-VEGF therapy in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) [Phase 1]
A Phase 1 clinical trial update for the V934/V935 cancer vaccine (V934-002) in selected solid tumors; the study is completed and results hav…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of RO4929097, a gamma-secretase/Notch pathway inhibitor, in combination with temsirolimus for advanced solid tumors has comple…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating Axitinib (AG-013736) with and without dose titration in patients with renal cell carcinoma; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial comparing Tarceva plus Avastin versus Avastin alone in metastatic renal cell carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Sunitinib Drug Levels and Outcomes in Kidney Cancer
This clinical trial update reports on the relationship between sunitinib drug levels and outcomes in renal cell carcinoma (kidney cancer).
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating Bevacizumab plus Everolimus (RAD001) versus Bevacizumab with Interferon alfa-2a as first-line therapy for renal cel…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Sequential Study to Treat Renal Cell Carcinoma [Phase 3]
A Phase 3 clinical trial for renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors [Phase 1]
Phase 1 dose-escalation study of TH-302 in combination with sunitinib for advanced renal cell carcinoma, gastrointestinal stromal tumors, an…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody [Phase 3]
Phase 3 trial for pre-surgical detection of clear cell renal cell carcinoma using radiolabeled G250-antibody has completed with results post…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the combination of sunitinib malate and bevacizumab in kidney cancer and other solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib (OSI-774) in combination with bevacizumab for metastatic renal cell carcinoma has completed. The update s…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma [Phase 1]
Phase 1 study evaluating GC1008 (fresolimumab), a TGF-beta antagonist, for safety and preliminary efficacy in renal cell carcinoma and malig…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Pazopanib in Second-line Therapy in Renal Cell Carcinoma [Phase 2]
A Phase 2 trial update evaluating pazopanib as second-line therapy for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus peripheral stem cell transplantation in melanoma or metastatic kidney cancer has complet…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [Phase 1]
Phase 1 study evaluating AFP464 in patients with metastatic or unresectable solid tumors completed; the trial enrolled patients with various…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Perifosine + Sunitinib Malate for Patients With Advanced Cancers [Phase 1]
Phase 1 study evaluating perifosine in combination with sunitinib malate for patients with advanced cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy [NA]
A completed clinical trial comparing a nefopam-propacetamol combination with propacetamol for postoperative quality of recovery after laparo…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers [Phase 1]
This document reports the completion of a Phase I study evaluating perifosine in combination with sorafenib in patients with advanced cancer…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy [NA]
This trial evaluated whether ketorolac and remote ischemic preconditioning can reduce renal ischemia-reperfusion injury during partial nephr…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and sirolimus for metastatic renal cell carcinoma has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating palliative radiofrequency ablation for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment [Phase 4]
A Phase 4 trial evaluating everolimus in patients with metastatic renal cell carcinoma after progression on bevacizumab has completed, repor…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland
This completed clinical trial compared the cost and effectiveness of sunitinib versus interferon-alpha in treating renal cell carcinoma in F…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer [Phase 3]
Phase 3 trial update for axitinib in metastatic renal cell cancer has completed; results posted in 2014.